University of Utah Health: HIV Drug Based in Research by the Sundquist Lab is Science's 2024 Breakthrough of the Year
December 13, 2024
December 13, 2024
SALT LAKE CITY, Utah, Dec. 13 (TNSres) -- The University of Utah Health issued the following news release:
Wesley Sundquist, PhD, Samuels Professor and chair of biochemistry at the University of Utah, laid the foundation for the development of a highly effective, long-lasting prophylactic against HIV, which has been named the Breakthrough of the Year by Science, a top scientific journal. The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead . . .
Wesley Sundquist, PhD, Samuels Professor and chair of biochemistry at the University of Utah, laid the foundation for the development of a highly effective, long-lasting prophylactic against HIV, which has been named the Breakthrough of the Year by Science, a top scientific journal. The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead . . .